2 June 2019 - Adults with diabetes will now have greater access to Fiasp, a fast-acting mealtime insulin, thanks to its listing on the Pharmaceutical Benefits Scheme.
Adults with diabetes now have greater access to a rapid-acting insulin which can be taken just before eating a meal.
Senior endocrinologist at St Vincent's Hospital Melbourne David O'Neal says the medicine gives diabetes patients more flexibility and control.